Details for: RPL12

Gene ID: 6136

Gene Type:  Protein-coding  - A gene that serves as a template for producing a messenger RNA (mRNA) molecule, which is then translated into a functional protein.

Symbol: RPL12

Ensembl ID: ENSG00000197958

Description: ribosomal protein L12

Selected Context(s):  Overall

Cell Significance Landscape

Contexts:

Associated with

Significant Cells

Cell Significance Index (CSI) scores for the chosen context(s)

  • central memory CD4-positive, alpha-beta T cell CL0000904
    CSI 151.66
    rCSI 89.57%
    PRS 1.43
  • hematopoietic stem cell CL0000037
    CSI 141.84
    rCSI 94.27%
    PRS 1.22
  • central memory CD8-positive, alpha-beta T cell CL0000907
    CSI 135.03
    rCSI 90.97%
    PRS 1.24
  • melanocyte CL0000148
    CSI 134.68
    rCSI 99.75%
    PRS 0.98
  • CD4-positive, alpha-beta memory T cell CL0000897
    CSI 133.14
    rCSI 95.58%
    PRS 1.4
  • naive thymus-derived CD8-positive, alpha-beta T cell CL0000900
    CSI 132.36
    rCSI 92.96%
    PRS 3.14
  • naive T cell CL0000898
    CSI 130.82
    rCSI 91.04%
    PRS 1.5
  • double negative thymocyte CL0002489
    CSI 129.32
    rCSI 89.9%
    PRS 1.2
  • CD16-positive, CD56-dim natural killer cell, human CL0000939
    CSI 125.94
    rCSI 83.93%
    PRS 2.91
  • plasmacytoid dendritic cell, human CL0001058
    CSI 125.04
    rCSI 87.3%
    PRS 1.08
  • class switched memory B cell CL0000972
    CSI 124.45
    rCSI 92.9%
    PRS 1.74
  • epithelial cell of lower respiratory tract CL0002632
    CSI 122.85
    rCSI 95.24%
    PRS 0.97
  • bronchus fibroblast of lung CL2000093
    CSI 119.53
    rCSI 97.12%
    PRS 1.07
  • T follicular helper cell CL0002038
    CSI 118.7
    rCSI 88.83%
    PRS 1.69
  • CD16-negative, CD56-bright natural killer cell, human CL0000938
    CSI 118.06
    rCSI 88.53%
    PRS 3.1
  • effector CD8-positive, alpha-beta T cell CL0001050
    CSI 117.53
    rCSI 89.39%
    PRS 1.36
  • common myeloid progenitor CL0000049
    CSI 116.43
    rCSI 94.14%
    PRS 1.01
  • skin fibroblast CL0002620
    CSI 115.34
    rCSI 99.43%
    PRS 1.72
  • CD14-low, CD16-positive monocyte CL0002396
    CSI 114.73
    rCSI 88.39%
    PRS 0.92
  • group 3 innate lymphoid cell CL0001071
    CSI 114.6
    rCSI 86.11%
    PRS 1.06
  • CD4-positive helper T cell CL0000492
    CSI 113.31
    rCSI 85.72%
    PRS 1.44
  • immature B cell CL0000816
    CSI 112.64
    rCSI 83.69%
    PRS 1.53
  • CD4-positive, alpha-beta thymocyte CL0000810
    CSI 111.5
    rCSI 89.31%
    PRS 1.93
  • mucosal invariant T cell CL0000940
    CSI 109.53
    rCSI 88.5%
    PRS 2.7
  • granulocyte monocyte progenitor cell CL0000557
    CSI 109.49
    rCSI 94.8%
    PRS 1.15
  • T-helper 17 cell CL0000899
    CSI 109.15
    rCSI 86.67%
    PRS 1.83
  • unswitched memory B cell CL0000970
    CSI 109.05
    rCSI 91.75%
    PRS 1.73
  • epithelial cell of lung CL0000082
    CSI 108.82
    rCSI 90.22%
    PRS 0.96
  • mature T cell CL0002419
    CSI 108.49
    rCSI 84.39%
    PRS 1.46
  • naive B cell CL0000788
    CSI 107.81
    rCSI 92.47%
    PRS 3.34
  • mature B cell CL0000785
    CSI 105.26
    rCSI 91.5%
    PRS 1.26
  • early lymphoid progenitor CL0000936
    CSI 105.22
    rCSI 92.42%
    PRS 1.15
  • neural crest cell CL0011012
    CSI 104.86
    rCSI 82.88%
    PRS 0.71
  • plasmablast CL0000980
    CSI 104.48
    rCSI 82.19%
    PRS 1.22
  • keratinocyte CL0000312
    CSI 104.01
    rCSI 87.19%
    PRS 1.24
  • goblet cell CL0000160
    CSI 103.32
    rCSI 97.63%
    PRS 1.07
  • intestine goblet cell CL0019031
    CSI 102.88
    rCSI 91.32%
    PRS 1.03
  • fibroblast of lung CL0002553
    CSI 102.53
    rCSI 95.42%
    PRS 1.02
  • megakaryocyte-erythroid progenitor cell CL0000050
    CSI 102.23
    rCSI 92.32%
    PRS 0.9
  • pro-B cell CL0000826
    CSI 101.41
    rCSI 83.98%
    PRS 1.03
  • activated CD4-positive, alpha-beta T cell CL0000896
    CSI 100.26
    rCSI 92.68%
    PRS 1.88
  • memory B cell CL0000787
    CSI 93.33
    rCSI 92.17%
    PRS 4.56
  • effector memory CD8-positive, alpha-beta T cell CL0000913
    CSI 93.18
    rCSI 84.87%
    PRS 1.61
  • hematopoietic precursor cell CL0008001
    CSI 92.58
    rCSI 95.24%
    PRS 1.53
  • fallopian tube secretory epithelial cell CL4030006
    CSI 91.82
    rCSI 88.39%
    PRS 1.07
  • CD4-positive, CD25-positive, alpha-beta regulatory T cell CL0000792
    CSI 90.34
    rCSI 88.72%
    PRS 1.64
  • intestinal epithelial cell CL0002563
    CSI 90
    rCSI 94.07%
    PRS 1.1
  • precursor B cell CL0000817
    CSI 89.38
    rCSI 78.29%
    PRS 1.39
  • respiratory basal cell CL0002633
    CSI 88.37
    rCSI 91.54%
    PRS 1.2
  • alveolar type 1 fibroblast cell CL4028004
    CSI 88.27
    rCSI 96.67%
    PRS 1.2
  • pancreatic D cell CL0000173
    CSI 88.22
    rCSI 86.77%
    PRS 1.14
  • double-positive, alpha-beta thymocyte CL0000809
    CSI 87.82
    rCSI 89.5%
    PRS 1.49
  • elicited macrophage CL0000861
    CSI 87.55
    rCSI 80.39%
    PRS 1.16
  • CD8-positive, alpha-beta memory T cell CL0000909
    CSI 86.04
    rCSI 89.86%
    PRS 3.32
  • ciliated epithelial cell CL0000067
    CSI 84.71
    rCSI 74.49%
    PRS 0.75
  • CD8-positive, alpha-beta cytotoxic T cell CL0000794
    CSI 83.76
    rCSI 100%
    PRS 1.79
  • activated CD8-positive, alpha-beta T cell CL0000906
    CSI 81.87
    rCSI 80.48%
    PRS 3.08
  • small pre-B-II cell CL0000954
    CSI 80.63
    rCSI 77.53%
    PRS 2.25
  • gamma-delta T cell CL0000798
    CSI 78.65
    rCSI 92.37%
    PRS 10.46
  • transit amplifying cell of colon CL0009011
    CSI 78.24
    rCSI 91.89%
    PRS 1.26
  • pancreatic A cell CL0000171
    CSI 77.87
    rCSI 81.58%
    PRS 1.11
  • fraction A pre-pro B cell CL0002045
    CSI 77.56
    rCSI 88.79%
    PRS 2.14
  • IgA plasma cell CL0000987
    CSI 76.16
    rCSI 77.96%
    PRS 1.94
  • activated type II NK T cell CL0000931
    CSI 74.9
    rCSI 84.3%
    PRS 1.73
  • common dendritic progenitor CL0001029
    CSI 74.69
    rCSI 93.73%
    PRS 1.3
  • CD1c-positive myeloid dendritic cell CL0002399
    CSI 74.31
    rCSI 89.76%
    PRS 1.18
  • naive thymus-derived CD4-positive, alpha-beta T cell CL0000895
    CSI 73.01
    rCSI 91.74%
    PRS 5.67
  • respiratory suprabasal cell CL4033048
    CSI 71.29
    rCSI 91.44%
    PRS 1.19
  • extravillous trophoblast CL0008036
    CSI 71.29
    rCSI 88.2%
    PRS 0.91
  • myofibroblast cell CL0000186
    CSI 71.07
    rCSI 98.43%
    PRS 1.48
  • CD4-positive, alpha-beta T cell CL0000624
    CSI 71.05
    rCSI 90.92%
    PRS 22.51
  • myeloid leukocyte CL0000766
    CSI 70.33
    rCSI 64.89%
    PRS 1.04
  • pulmonary ionocyte CL0017000
    CSI 69.75
    rCSI 84.91%
    PRS 1.3
  • CD14-positive monocyte CL0001054
    CSI 69.72
    rCSI 86.83%
    PRS 1.52
  • enteroendocrine cell CL0000164
    CSI 69.69
    rCSI 95.22%
    PRS 1.14
  • mature NK T cell CL0000814
    CSI 69.02
    rCSI 88.28%
    PRS 4.78
  • B cell CL0000236
    CSI 68.54
    rCSI 91.7%
    PRS 6.32
  • CD4-positive, alpha-beta cytotoxic T cell CL0000934
    CSI 67.46
    rCSI 92.68%
    PRS 2.21
  • conventional dendritic cell CL0000990
    CSI 67.42
    rCSI 56.28%
    PRS 3.62
  • M cell of gut CL0000682
    CSI 66.55
    rCSI 70.72%
    PRS 1.87
  • perivascular cell CL4033054
    CSI 65.92
    rCSI 90.11%
    PRS 1.18
  • interstitial cell of Cajal CL0002088
    CSI 65.71
    rCSI 83.64%
    PRS 1.2
  • club cell CL0000158
    CSI 65.62
    rCSI 96.12%
    PRS 1.22
  • effector memory CD4-positive, alpha-beta T cell CL0000905
    CSI 65.53
    rCSI 89.27%
    PRS 2.58
  • common lymphoid progenitor CL0000051
    CSI 65.44
    rCSI 87.45%
    PRS 1.97
  • chondrocyte CL0000138
    CSI 65.37
    rCSI 100%
    PRS 1.02
  • mucous neck cell CL0000651
    CSI 65.3
    rCSI 94.11%
    PRS 1.67
  • multi-ciliated epithelial cell CL0005012
    CSI 65.09
    rCSI 64.96%
    PRS 0.86
  • promyelocyte CL0000836
    CSI 64.63
    rCSI 93.22%
    PRS 1.43
  • mesodermal cell CL0000222
    CSI 64.6
    rCSI 77.55%
    PRS 1.03
  • endothelial cell of artery CL1000413
    CSI 64.32
    rCSI 94.24%
    PRS 6.35
  • acinar cell CL0000622
    CSI 64.22
    rCSI 94.17%
    PRS 1.36
  • peripheral nervous system neuron CL2000032
    CSI 63.98
    rCSI 87.17%
    PRS 0.94
  • enteric smooth muscle cell CL0002504
    CSI 63.14
    rCSI 90.11%
    PRS 1.17
  • epithelial cell CL0000066
    CSI 62.9
    rCSI 96.66%
    PRS 1.5
  • colon epithelial cell CL0011108
    CSI 62.77
    rCSI 65.75%
    PRS 0.96
  • myeloid dendritic cell CL0000782
    CSI 62.7
    rCSI 90.83%
    PRS 1.51
  • secretory cell CL0000151
    CSI 62.57
    rCSI 65.29%
    PRS 1.05
  • granulocyte CL0000094
    CSI 62.51
    rCSI 95.5%
    PRS 1.28
  • conjunctival epithelial cell CL1000432
    CSI 62.37
    rCSI 95.27%
    PRS 1.04
  • ependymal cell CL0000065
    CSI -47.2
    rCSI -95.7%
    PRS 0.4%
  • adipocyte CL0000136
    CSI -34.6
    rCSI -44.4%
    PRS 1.4%
  • pulmonary capillary endothelial cell CL4028001
    CSI -28.6
    rCSI -54.4%
    PRS 1.7%
  • mature astrocyte CL0002627
    CSI -25.7
    rCSI -100.0%
    PRS 2.9%
  • neural cell CL0002319
    CSI -19.3
    rCSI -73.0%
    PRS 2.5%
  • inhibitory interneuron CL0000498
    CSI -18.7
    rCSI -43.2%
    PRS 1.1%
  • professional antigen presenting cell CL0000145
    CSI -17.6
    rCSI -60.5%
    PRS 4.5%
  • kidney interstitial alternatively activated macrophage CL1000695
    CSI -17.4
    rCSI -45.4%
    PRS 1.3%
  • astrocyte of the cerebral cortex CL0002605
    CSI -17.3
    rCSI -38.8%
    PRS 0.7%
  • endocrine cell CL0000163
    CSI -15.9
    rCSI -81.6%
    PRS 4.6%
  • pvalb GABAergic cortical interneuron CL4023018
    CSI -13.4
    rCSI -16.7%
    PRS 0.6%
  • erythroid lineage cell CL0000764
    CSI -13.4
    rCSI -86.4%
    PRS 3.0%
  • kidney proximal convoluted tubule epithelial cell CL1000838
    CSI -12.6
    rCSI -100.0%
    PRS 20.7%
  • kidney collecting duct principal cell CL1001431
    CSI -12.2
    rCSI -61.3%
    PRS 7.3%
  • cell of skeletal muscle CL0000188
    CSI -10.8
    rCSI -100.0%
    PRS 6.9%
  • squamous epithelial cell CL0000076
    CSI -10.8
    rCSI -25.6%
    PRS 1.4%
  • differentiation-committed oligodendrocyte precursor CL4023059
    CSI -10.6
    rCSI -19.2%
    PRS 1.3%
  • regular ventricular cardiac myocyte CL0002131
    CSI -10.3
    rCSI -64.3%
    PRS 0.9%
  • cardiac endothelial cell CL0010008
    CSI -8.9
    rCSI -35.9%
    PRS 1.3%
  • VIP GABAergic cortical interneuron CL4023016
    CSI -8.8
    rCSI -10.5%
    PRS 0.7%
  • kidney collecting duct intercalated cell CL1001432
    CSI -8.6
    rCSI -61.7%
    PRS 4.8%
  • cord blood hematopoietic stem cell CL2000095
    CSI -8.4
    rCSI -100.0%
    PRS 8.4%
  • diffuse bipolar 3b cell CL4033030
    CSI -8.2
    rCSI -54.6%
    PRS 2.8%
  • primordial germ cell CL0000670
    CSI -8.2
    rCSI -40.7%
    PRS 7.8%
  • glutamatergic neuron CL0000679
    CSI -8.0
    rCSI -16.5%
    PRS 1.3%
  • exhausted T cell CL0011025
    CSI -7.5
    rCSI -100.0%
    PRS 6.1%
  • diffuse bipolar 6 cell CL4033032
    CSI -7.3
    rCSI -38.2%
    PRS 3.5%
  • rod bipolar cell CL0000751
    CSI -7.3
    rCSI -13.0%
    PRS 0.9%
  • diffuse bipolar 3a cell CL4033029
    CSI -6.8
    rCSI -46.5%
    PRS 2.7%
  • Bergmann glial cell CL0000644
    CSI -6.8
    rCSI -9.3%
    PRS 1.2%
  • renal interstitial pericyte CL1001318
    CSI -6.4
    rCSI -17.6%
    PRS 1.1%
  • H2 horizontal cell CL0004218
    CSI -6.2
    rCSI -30.6%
    PRS 2.2%
  • diffuse bipolar 2 cell CL4033028
    CSI -5.9
    rCSI -45.8%
    PRS 3.1%
  • H1 horizontal cell CL0004217
    CSI -4.4
    rCSI -17.6%
    PRS 3.1%
  • epicardial adipocyte CL1000309
    CSI -3.1
    rCSI -10.1%
    PRS 2.0%
  • kidney granular cell CL0000648
    CSI -3.0
    rCSI -43.3%
    PRS 15.4%
  • platelet CL0000233
    CSI -2.8
    rCSI -11.5%
    PRS 3.2%
  • glycinergic amacrine cell CL4030028
    CSI -2.4
    rCSI -6.2%
    PRS 1.7%
  • cerebellar granule cell CL0001031
    CSI -1.7
    rCSI -2.5%
    PRS 1.1%
  • indirect pathway medium spiny neuron CL4023029
    CSI -1.4
    rCSI -33.2%
    PRS 0.8%
  • macroglial cell CL0000126
    CSI -0.8
    rCSI -2.1%
    PRS 1.9%
  • endocardial cell CL0002350
    CSI -0.4
    rCSI -1.9%
    PRS 1.9%
  • L6b glutamatergic cortical neuron CL4023038
    CSI 0.0
    rCSI 0.0%
    PRS 0.7%
  • kidney resident macrophage CL1000698
    CSI 0.2
    rCSI 3.7%
    PRS 27.4%
  • renal intercalated cell CL0005010
    CSI 0.3
    rCSI 2.8%
    PRS 9.5%
  • immature innate lymphoid cell CL0001082
    CSI 0.8
    rCSI 25.0%
    PRS 19.7%
  • endothelial cell of vascular tree CL0002139
    CSI 0.9
    rCSI 4.7%
    PRS 2.9%
  • hepatic stellate cell CL0000632
    CSI 1.1
    rCSI 4.1%
    PRS 0.9%
  • choroid plexus epithelial cell CL0000706
    CSI 1.1
    rCSI 1.9%
    PRS 0.8%
  • tracheobronchial goblet cell CL0019003
    CSI 1.3
    rCSI 21.2%
    PRS 26.7%
  • fast muscle cell CL0000190
    CSI 1.4
    rCSI 5.3%
    PRS 6.6%
  • caudal ganglionic eminence derived cortical interneuron CL4023064
    CSI 1.4
    rCSI 2.4%
    PRS 0.6%
  • Schwann cell CL0002573
    CSI 1.4
    rCSI 4.0%
    PRS 1.4%
  • kidney loop of Henle epithelial cell CL1000909
    CSI 1.5
    rCSI 31.0%
    PRS 10.2%
  • forebrain neuroblast CL1000042
    CSI 1.9
    rCSI 20.8%
    PRS 16.6%
  • group 3 innate lymphoid cell, human CL0001078
    CSI 2.0
    rCSI 41.6%
    PRS 20.2%
  • sst GABAergic cortical interneuron CL4023017
    CSI 2.2
    rCSI 2.9%
    PRS 0.7%
  • slow muscle cell CL0000189
    CSI 2.3
    rCSI 30.7%
    PRS 15.2%
  • midzonal region hepatocyte CL0019028
    CSI 2.4
    rCSI 5.7%
    PRS 1.9%
  • hepatic pit cell CL2000054
    CSI 2.6
    rCSI 36.1%
    PRS 14.0%
  • retinal ganglion cell CL0000740
    CSI 2.6
    rCSI 5.8%
    PRS 0.8%
  • odontoblast CL0000060
    CSI 2.7
    rCSI 61.0%
    PRS 6.3%
  • NKp44-negative group 3 innate lymphoid cell, human CL0001080
    CSI 2.8
    rCSI 85.9%
    PRS 15.1%
  • B-1 B cell CL0000819
    CSI 2.9
    rCSI 73.6%
    PRS 6.4%
  • uterine smooth muscle cell CL0002601
    CSI 2.9
    rCSI 19.0%
    PRS 8.2%
  • eye photoreceptor cell CL0000287
    CSI 3.0
    rCSI 34.2%
    PRS 4.7%
  • cone retinal bipolar cell CL0000752
    CSI 3.1
    rCSI 40.3%
    PRS 7.5%
  • pluripotent stem cell CL0002248
    CSI 3.2
    rCSI 94.6%
    PRS 2.6%
  • retinal pigment epithelial cell CL0002586
    CSI 3.4
    rCSI 6.7%
    PRS 1.2%
  • lung microvascular endothelial cell CL2000016
    CSI 3.4
    rCSI 66.0%
    PRS 3.8%
  • Merkel cell CL0000242
    CSI 3.5
    rCSI 81.4%
    PRS 7.4%
  • mesenchymal lymphangioblast CL0005021
    CSI 3.5
    rCSI 92.4%
    PRS 6.0%
  • osteoblast CL0000062
    CSI 3.6
    rCSI 88.7%
    PRS 10.2%
  • epithelial cell of urethra CL1000296
    CSI 3.7
    rCSI 93.4%
    PRS 3.7%
  • kidney loop of Henle thick ascending limb epithelial cell CL1001106
    CSI 3.7
    rCSI 32.1%
    PRS 2.9%
  • kidney connecting tubule principal cell CL4030018
    CSI 3.8
    rCSI 27.7%
    PRS 16.9%
  • endothelial cell of uterus CL0009095
    CSI 3.9
    rCSI 28.2%
    PRS 2.9%
  • prostate gland microvascular endothelial cell CL2000059
    CSI 3.9
    rCSI 93.8%
    PRS 3.8%
  • kidney distal convoluted tubule epithelial cell CL1000849
    CSI 4.0
    rCSI 41.8%
    PRS 1.8%
  • double negative T regulatory cell CL0011024
    CSI 4.2
    rCSI 80.5%
    PRS 9.9%
  • periportal region hepatocyte CL0019026
    CSI 4.4
    rCSI 17.1%
    PRS 1.8%
  • B-2 B cell CL0000822
    CSI 4.5
    rCSI 95.8%
    PRS 6.8%
  • kidney interstitial cell CL1000500
    CSI 4.6
    rCSI 74.5%
    PRS 12.3%
  • enteric neuron CL0007011
    CSI 4.9
    rCSI 72.8%
    PRS 3.0%
  • enterocyte of epithelium of small intestine CL1000334
    CSI 5.2
    rCSI 80.1%
    PRS 2.7%
  • follicular dendritic cell CL0000442
    CSI 5.3
    rCSI 85.1%
    PRS 6.3%
  • hair follicular keratinocyte CL2000092
    CSI 5.4
    rCSI 93.7%
    PRS 3.9%
  • mesangial cell CL0000650
    CSI 5.4
    rCSI 22.0%
    PRS 2.1%
  • bronchiolar smooth muscle cell CL4033017
    CSI 5.4
    rCSI 81.0%
    PRS 3.5%
  • cerebral cortex pyramidal neuron CL4023111
    CSI 5.5
    rCSI 33.9%
    PRS 4.4%
  • neural progenitor cell CL0011020
    CSI 5.5
    rCSI 24.4%
    PRS 1.1%
  • endothelial cell of periportal hepatic sinusoid CL0019021
    CSI 5.7
    rCSI 26.0%
    PRS 4.3%
  • immature alpha-beta T cell CL0000790
    CSI 5.7
    rCSI 81.8%
    PRS 17.0%
  • parietal epithelial cell CL1000452
    CSI 5.8
    rCSI 15.5%
    PRS 1.1%
  • pre-conventional dendritic cell CL0002010
    CSI 5.8
    rCSI 77.0%
    PRS 3.5%
  • stratified epithelial cell CL0000079
    CSI 5.8
    rCSI 36.1%
    PRS 4.9%
  • cardiac muscle cell CL0000746
    CSI 6.0
    rCSI 8.6%
    PRS 0.9%
  • endothelial cell of arteriole CL1000412
    CSI 6.1
    rCSI 33.7%
    PRS 5.8%
  • enterocyte of epithelium of large intestine CL0002071
    CSI 6.2
    rCSI 32.4%
    PRS 2.2%
  • NKp44-positive group 3 innate lymphoid cell, human CL0001079
    CSI 6.2
    rCSI 87.7%
    PRS 33.3%

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration

Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.

Comma-separated if multiple.
Comma-separated if multiple.

Legend:
  • Query Gene
  • Node Color (Target Cell CSI, relative to current network):
    • Very High
    • High
    • Medium
    • Low
    • Very Low
    • CSI N/A
  • Node Size: Proportional to Target Cell CSI magnitude
  • STRING PPI Edge
  • Shared Pathway Edge (ONTOLOGY)

Loading network (please wait)...

Other Information

This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.

## Summary [RPL12](/details-gene/6136) (Ribosomal Protein L12) is a protein-coding gene located on chromosome 9q33.3. As its name suggests, it is an integral structural component of the large 60S ribosomal subunit ([GO:0003735](https://www.ebi.ac.uk/QuickGO/term/GO:0003735)). Its primary function is to participate in the process of [cytoplasmic translation](/details-gene/GO:0002181), binding to both rRNA ([GO:0070180](https://www.ebi.ac.uk/QuickGO/term/GO:0070180)) and other proteins ([GO:0005515](https://www.ebi.ac.uk/QuickGO/term/GO:0005515)) to facilitate protein synthesis. **Overall**, expression data reveals that [RPL12](/details-gene/6136) has high significance in cells with high metabolic and proliferative demands, particularly within the hematopoietic system, including [hematopoietic stem cell](/details-cell/CL0000037) and various subsets of activated and memory T lymphocytes, such as [central memory CD4-positive, alpha-beta T cell](/details-cell/CL0000904). Its fundamental role in protein synthesis makes it a critical housekeeping gene, essential for cellular growth, maintenance, and function. ## Cellular Roles and Expression Landscape The expression profile of [RPL12](/details-gene/6136) underscores its fundamental role in cellular metabolism and proliferation. The gene shows the highest significance in a variety of immune cells, suggesting it is a crucial workhorse for the hematopoietic system. Top cell types include [central memory CD4-positive, alpha-beta T cell](/details-cell/CL0000904), [hematopoietic stem cell](/details-cell/CL0000037), [central memory CD8-positive, alpha-beta T cell](/details-cell/CL0000907), and [naive T cell](/details-cell/CL0000898). This pattern is consistent with the high translational demands required for immune surveillance, lymphocyte activation, differentiation, and the self-renewal capacity of stem cells. High significance is also noted in other metabolically active cell types, such as [melanocyte](/details-cell/CL0000148) and [epithelial cell of lower respiratory tract](/details-cell/CL0002632), which are involved in pigment production and maintaining mucosal barriers, respectively. Conversely, [RPL12](/details-gene/6136) shows markedly low significance in cell types that are terminally differentiated, quiescent, or have lower metabolic activity. The list of anti-markers is dominated by cells of the nervous system, including [ependymal cell](/details-cell/CL0000065), [mature astrocyte](/details-cell/CL0002627), and various interneurons. Additionally, its low significance in [adipocyte](/details-cell/CL0000136) and [cell of skeletal muscle](/details-cell/CL0000188) further suggests that its expression is tightly correlated with proliferative potential and active protein export rather than the maintenance of large, post-mitotic cells. This expression landscape defines [RPL12](/details-gene/6136) as a key indicator of cellular biosynthetic activity. ## Pathways and Molecular Function Functionally, [RPL12](/details-gene/6136) is deeply embedded in the core machinery of protein synthesis. Its annotation as a [structural constituent of ribosome](/details-gene/GO:0003735) is central to its role in multiple Reactome pathways governing [Translation](/details-gene/R-HSA-72766), including [Eukaryotic translation initiation](/details-gene/R-HSA-72613), [Peptide chain elongation](/details-gene/R-HSA-156902), and [Eukaryotic translation termination](/details-gene/R-HSA-72764). This involvement is consistent with its high expression in rapidly dividing or protein-secreting cells identified in the expression landscape. Beyond its core translational role, [RPL12](/details-gene/6136) is implicated in broader biological processes that rely on controlled protein synthesis. Its participation in pathways such as [Developmental biology](/details-gene/R-HSA-1266738), [Nervous system development](/details-gene/R-HSA-9675108), and [Cellular responses to stress](/details-gene/R-HSA-2262752) highlights that the regulation of ribosome biogenesis and function is a critical node for managing cell growth, differentiation, and adaptation to environmental stimuli. Furthermore, its inclusion in pathways like [Influenza infection](/details-gene/R-HSA-168255) indicates that the host translational machinery, of which [RPL12](/details-gene/6136) is a key component, is often co-opted during viral replication, making it relevant to the study of [Infectious disease](/details-gene/R-HSA-5663205). ## Research Directions The ubiquitous and essential nature of [RPL12](/details-gene/6136) makes it a difficult direct target, but its differential importance across cell states presents opportunities for further research into the regulation of translation in health and disease. **Proposed Hypotheses:** 1. Given its high significance in memory T cells and hematopoietic stem cells, the expression and post-translational modification of [RPL12](/details-gene/6136) may be dynamically regulated during lymphocyte activation and stem cell differentiation. This regulation could contribute to the formation of "specialized ribosomes" that preferentially translate specific subsets of mRNAs required for distinct cell fates (e.g., effector vs. memory T cells). 2. As ribosome biogenesis is a hallmark of cancer, aberrant upregulation of [RPL12](/details-gene/6136) could be a key dependency in hematological malignancies. The elevated demand for protein synthesis in leukemia or lymphoma cells may render them particularly sensitive to perturbations in [RPL12](/details-gene/6136) levels compared to their healthy hematopoietic counterparts. **Experimental Approach:** To test the hypothesis that [RPL12](/details-gene/6136) regulation influences T cell fate, one could utilize a CRISPR interference (CRISPRi) system to achieve partial, titratable knockdown of [RPL12](/details-gene/6136) in primary human naive [CD4-positive, alpha-beta T cell](/details-cell/CL0000895). Following activation, these cells could be cultured under Th1-polarizing conditions. The impact of reduced [RPL12](/details-gene/6136) levels would be assessed by measuring proliferation (e.g., via CellTrace Violet dilution), effector cytokine production (e.g., IFN-γ by intracellular staining or ELISA), and the expression of key lineage-defining transcription factors (e.g., T-bet). Ribosome profiling coupled with mass spectrometry could then be employed to determine if [RPL12](/details-gene/6136) knockdown alters the translational efficiency of specific mRNA transcripts critical for T cell effector function. **Therapeutic Potential:** As a core component of the ribosome, [RPL12](/details-gene/6136) is not an ideal direct therapeutic target due to the high risk of on-target toxicity in healthy, proliferating cells. However, its role in enabling hyperproliferation makes it conceptually relevant for indirect therapeutic strategies, particularly in oncology. The therapeutic approach would be **inhibition**. Instead of targeting the protein itself, strategies could focus on upstream regulators of [RPL12](/details-gene/6136) transcription or post-translational modifications that are specific to cancer cells. Such an approach could selectively dampen the translational capacity of malignant cells, providing a therapeutic window while sparing healthy tissues.

Genular Protein ID: 3963943269

Symbol: RL12_HUMAN

Name: 60S ribosomal protein L12

UniProtKB Accession Codes:

Database IDs:

Citations:

PubMed ID: 8441690

Title: The primary structure of human ribosomal protein L12.

PubMed ID: 8441690

DOI: 10.1093/nar/21.3.749

PubMed ID: 15164053

Title: DNA sequence and analysis of human chromosome 9.

PubMed ID: 15164053

DOI: 10.1038/nature02465

PubMed ID: 15489334

Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).

PubMed ID: 15489334

DOI: 10.1101/gr.2596504

PubMed ID: 14654843

Title: Proteomic characterization of the human centrosome by protein correlation profiling.

PubMed ID: 14654843

DOI: 10.1038/nature02166

PubMed ID: 16964243

Title: A probability-based approach for high-throughput protein phosphorylation analysis and site localization.

PubMed ID: 16964243

DOI: 10.1038/nbt1240

PubMed ID: 18691976

Title: Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.

PubMed ID: 18691976

DOI: 10.1016/j.molcel.2008.07.007

PubMed ID: 18669648

Title: A quantitative atlas of mitotic phosphorylation.

PubMed ID: 18669648

DOI: 10.1073/pnas.0805139105

PubMed ID: 19413330

Title: Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.

PubMed ID: 19413330

DOI: 10.1021/ac9004309

PubMed ID: 19608861

Title: Lysine acetylation targets protein complexes and co-regulates major cellular functions.

PubMed ID: 19608861

DOI: 10.1126/science.1175371

PubMed ID: 20068231

Title: Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.

PubMed ID: 20068231

DOI: 10.1126/scisignal.2000475

PubMed ID: 21269460

Title: Initial characterization of the human central proteome.

PubMed ID: 21269460

DOI: 10.1186/1752-0509-5-17

PubMed ID: 21406692

Title: System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.

PubMed ID: 21406692

DOI: 10.1126/scisignal.2001570

PubMed ID: 23186163

Title: Toward a comprehensive characterization of a human cancer cell phosphoproteome.

PubMed ID: 23186163

DOI: 10.1021/pr300630k

PubMed ID: 24524803

Title: A new system for naming ribosomal proteins.

PubMed ID: 24524803

DOI: 10.1016/j.sbi.2014.01.002

PubMed ID: 24275569

Title: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.

PubMed ID: 24275569

DOI: 10.1016/j.jprot.2013.11.014

PubMed ID: 25944712

Title: N-terminome analysis of the human mitochondrial proteome.

PubMed ID: 25944712

DOI: 10.1002/pmic.201400617

PubMed ID: 28112733

Title: Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.

PubMed ID: 28112733

DOI: 10.1038/nsmb.3366

PubMed ID: 36638793

Title: An E3 ligase network engages GCN1 to promote the degradation of translation factors on stalled ribosomes.

PubMed ID: 36638793

DOI: 10.1016/j.cell.2022.12.025

PubMed ID: 23636399

Title: Structures of the human and Drosophila 80S ribosome.

PubMed ID: 23636399

DOI: 10.1038/nature12104

PubMed ID: 25901680

Title: Structure of the human 80S ribosome.

PubMed ID: 25901680

DOI: 10.1038/nature14427

Sequence Information:

  • Length: 165
  • Mass: 17819
  • Checksum: 7EFD783A8ED350F9
  • Sequence:
  • MPPKFDPNEI KVVYLRCTGG EVGATSALAP KIGPLGLSPK KVGDDIAKAT GDWKGLRITV 
    KLTIQNRQAQ IEVVPSASAL IIKALKEPPR DRKKQKNIKH SGNITFDEIV NIARQMRHRS 
    LARELSGTIK EILGTAQSVG CNVDGRHPHD IIDDINSGAV ECPAS